Podcast 77: We revisit a conversation on treating community-acquired pneumonia according to the guidelines (and we’ve got current news).

Our attempts to get an interview with a researcher were unavailing, so we’ve  gone to plan B and repeat a useful look at treating community-acquired pneumonia according to guideline recommendations.

Please leave comments and complaints at jelia@jwatch.org. You can call and voice these at 1-617-440-4374.

Interview-related links:

• Community-Acquired Pneumonia: Guideline-Compliant Treatment Is Better
• IDSA/ATS guidelines

News-related links:

• Evaluating long-term risk via glycated hemoglobin
• Usefulness of aspirin in lowering risk in patients with abnormal ankle-brachial ratios
• Carotid endarterectomy versus stenting in patients at high risk
• Kapidex changes its name to Dexilant

The post Podcast 77: We revisit a conversation on treating community-acquired pneumonia according to the guidelines (and we’ve got current news). first appeared on Clinical Conversations.